MERRIMAN CURHAN FORD GROUP, INC. 600 CALIFORNIA STREET 9TH FLOOR SAN FRANCISCO, CA 94108 August 27, 2009 Ronald Chez c/o Barry Fischer Thompson Coburn Fagel Haber 55 E Monroe Street 37 Floor Chicago, IL 60603Investors' Rights Agreement • August 31st, 2009 • Merriman Curhan Ford Group, Inc. • Security brokers, dealers & flotation companies
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • October 2nd, 2024 • Septerna, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the 28th day of June, 2023, by and among Septerna, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and collectively, the “Investors”.
AMYLYX PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT July 1, 2021Investors’ Rights Agreement • October 20th, 2021 • Amylyx Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 1st day of July, 2021 (the “Effective Date”) by and among AMYLYX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor” and any additional investor that becomes a party to this Agreement in accordance with Section 6.9 hereof.
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • January 5th, 2024 • ArriVent Biopharma, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of December 16, 2022, by and among ArriVent BioPharma, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • November 13th, 2023 • Delaware
This Investors’ Rights Agreement (this “Agreement”) by and among Tetrous, Inc., a Delaware corporation (the “Company”) and each of the persons and entities holding outstanding securities of the Company and executing a counterpart signature page to this Agreement (each, an “Investor” and collectively, the “Investors”), is made as of the date set forth on the Company’s signature page below. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 4.
OPTI-HARVEST, INC. INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • June 26th, 2023 • Opti-Harvest, Inc. • Farm machinery & equipment • Delaware
This Investors’ Rights Agreement (this “Agreement”) is made as of April ___, 2023, by and among Opti-Harvest, Inc., a Delaware corporation (the “Company”), and the persons and entities (each, an “Investor” and collectively, the “Investors”) listed on Exhibit A hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.
INVESTORS RIGHTS AGREEMENTInvestors Rights Agreement • August 29th, 2024 • Tesseract Collective, Inc. • Finance services • Delaware
THIS INVESTORS RIGHTS AGREEMENT (this “Agreement”), is made as of October 10, 2023, by and among Tesseract Collective, Inc., a Delaware corporation, dba Tesseract Icons (the “Company”), and Homebase Ltd., a Bahamian limited corporation (“Homebase”), as listed on Schedule A hereto and referred to in this Agreement as an “Investor”.
RECITALSInvestors' Rights Agreement • July 16th, 2004 • Odimo INC • New York
NKARTA, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT August 27, 2019Investors’ Rights Agreement • June 19th, 2020 • Nkarta, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 27th day of August, 2019, by and among Nkarta, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto (together with any subsequent investors or transferees who become parties to this Agreement in accordance with Section 6.9 hereof, each an “Investor” and together the “Investors”).
RECITALSInvestors' Rights Agreement • September 18th, 2009 • Merriman Curhan Ford Group, Inc. • Security brokers, dealers & flotation companies • Delaware
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • February 14th, 2022 • Dynamics Special Purpose Corp. • Blank checks • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 22nd day of October, 2020, by and among Senti Biosciences, Inc., a Delaware corporation (the “Company”) and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
SEQUOIA VACCINES, INC. 2021 INVESTORS’ RIGHTS AGREEMENTInvestors' Rights Agreement • November 6th, 2023 • Sequoia Vaccines, Inc. • Biological products, (no disgnostic substances) • Missouri
THIS 2021 INVESTORS’ RIGHTS AGREEMENT (“Agreement”) is made as of ____April 30__, 2021 by and among Sequoia Vaccines, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A (each of which is referred to in this Agreement as an “Investor”), and any additional investor that becomes a party to this Agreement in accordance with Section 6.9 hereof. This Agreement supersedes and replaces in its entirety that 2020 Amended and Restated Investors’ Rights Agreement dated April 6, 2020 by and among the Company and the other parties thereto.
EX-4.1 4 a2235870zex-4_1.htm EX-4.1 Execution Version NEON THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT DECEMBER 28, 2016 Page Schedule A - Schedule of Investors NEON THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS...Investors’ Rights Agreement • May 5th, 2020 • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of December 28, 2016, by and among Neon Therapeutics, Inc., a Delaware corporation (the “Company”), and each investor listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • July 18th, 2024 • Upstream Bio, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the 6th day of June, 2023, by and among Upstream Bio, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder” or collectively as “Key Holders”.
RECITALSInvestors Rights Agreement • May 26th, 2006 • Light Sciences Oncology Inc • Surgical & medical instruments & apparatus • Washington
SAMSARA NETWORKS INC. SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • November 19th, 2021 • Samsara Inc. • Services-computer integrated systems design • California
This Seventh Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made and entered into as of January 13, 2021 by and among Samsara Networks Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor,” any Additional Purchaser (as defined in that certain Extension Series F Preferred Stock Purchase Agreement, dated as of May 15, 2020, by and among the Company and certain of the Investors (the “Purchase Agreement”)) that becomes a party to this Agreement in accordance with Section 7.14 hereof and any holder of a Lender Warrant that becomes a party to this Agreement in accordance with Section 7.14 hereof.
STENTOR, INC.Investors' Rights Agreement • November 19th, 2004 • Stentor Inc • Delaware
SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT by and among UXIN LIMITED MR. KUN DAI XIN GAO GROUP LIMITED ASTRAL SUCCESS LIMITED ABUNDANT GRACE INVESTMENT LIMITED and ABUNDANT GLORY INVESTMENT L.P. Dated March 26, 2024Investors’ Rights Agreement • July 31st, 2024 • Uxin LTD • Services-business services, nec • Hong Kong
A Certain Investors are the holders of the Company’s Senior Preferred Shares and possess information rights, participation rights, rights of first refusal, co-sale rights and other rights pursuant to that certain Amended and Restated Investors’ Rights Agreement dated July 27, 2022, by and among the Company, the Investors and the Principal Parties (the “Prior Agreement”).
RECITALSInvestors' Rights Agreement • November 22nd, 2000 • Combimatrix Corp • Delaware
EXHIBIT 4.1 AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT This Amended and Restated Investors' Rights Agreement (this "Agreement") is made and entered into as of __________ __, 2000, by and between eCommercial.com, Inc., a Nevada corporation (the...Investors' Rights Agreement • April 3rd, 2000 • Mindarrow Systems Inc • Services-business services, nec • California
THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • September 20th, 2024 • Camp4 Therapeutics Corp • Pharmaceutical preparations • Delaware
THIS THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of June 3, 2022, by and among Camp4 Therapeutics Corporation, a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
AMENDMENT NO. 1 TO AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENTInvestors' Rights Agreement • December 23rd, 2003 • Santarus Inc
Page 1. REGISTRATION RIGHTS 1 1.1 DEFINITIONS 1 1.2 REQUEST FOR REGISTRATION 2 1.3 COMPANY REGISTRATION 4 1.4 FORM S-3 REGISTRATION 4 1.5 OBLIGATIONS OF THE COMPANY 5 1.6 FURNISH INFORMATION 6 1.7 EXPENSES OF REGISTRATION 6 1.8 UNDERWRITING...Investors Rights Agreement • September 27th, 2001 • Techne Corp /Mn/ • Biological products, (no disgnostic substances) • New York
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT NEUMORA THERAPEUTICS, INC. September 22, 2022Investors’ Rights Agreement • August 25th, 2023 • Neumora Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of September 22, 2022, by and among Neumora Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the investors in the Company’s Series B Preferred Stock (the “Series B Investors”), the investors in the Company’s Series A-2 Preferred Stock (the “Series A-2 Investors”), and the investors in the Company’s Series A-1 Preferred Stock (the “Series A-1 Investors,” together with the Series A-2 Investors, the “Series A Investors,” and together with the Series B Investors, the “Investors”) listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
Exhibit C FIBERNET TELECOM GROUP, INC. INVESTOR'S RIGHTS AGREEMENT October 30, 2002 TABLE OF CONTENTSInvestor's Rights Agreement • November 12th, 2002 • Bank One Corp • National commercial banks • New York
RUBRIK, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT December 7, 2018Investors’ Rights Agreement • April 1st, 2024 • Rubrik, Inc. • Services-prepackaged software • California
This AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of the 7th day of December, 2018 by and among Rubrik, Inc., a Delaware corporation (the “Company”), the investors listed on Schedule A hereto, each of which is herein referred to as an “Investor” and collectively as the “Investors”, and the holders of Common Stock (as defined below) listed on Schedule B hereto, each of which is herein referred to as a “Common Holder” and collectively as the “Common Holders”.
EX-4.02 8 d403417dex402.htm EX-4.02 SONOS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT July 18, 2012 Page SONOS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • May 5th, 2020 • Delaware
This Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of July 18, 2012, by and among Sonos, Inc., a Delaware corporation (the “Company”), the persons and entities (each a “Common Holder” and collectively, the “Common Holders”) listed on Exhibit A hereto, and the persons and entities (each, an “Investor” and collectively, the “Investors”) listed on Exhibit B hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.
ACCENTIA BIOPHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • September 2nd, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Florida
This Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of January 7, 2005 by and among ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation, having its principal place of business located at 5310 Cypress Center Drive, Suite 101, Tampa, FL 33609 (the “Company”), and Pharmaceutical Product Development, Inc., a North Carolina corporation, having its principal place of business located at 3151 South 17th Street, Wilmington, NC 28412 (“PPD”), and supersedes and replaces in its entirety that certain Investors’ Rights Agreement dated January 9, 2004 by and between the Company and PPD (the “Original Agreement”).
RECITALSInvestors' Rights Agreement • June 1st, 2009 • Duoyuan Global Water Inc. • New York
IRHYTHM TECHNOLOGIES, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT May 16, 2014Investors’ Rights Agreement • October 7th, 2016 • iRhythm Technologies, Inc. • Surgical & medical instruments & apparatus • California
This Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of May 16, 2014, by and among iRhythm Technologies, Inc., a Delaware corporation (the “Company”), and the persons and entities (each, an “Investor” and collectively, the “Investors”) listed on Exhibit A hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.
EX-10.1 2 d782664dex101.htm EX-10.1 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT August 5, 2016 To each of the Purchasers named in Exhibit A of the Series D-1 Convertible Participating Preferred Stock Purchase Agreement of even date herewith...Investors’ Rights Agreement • May 5th, 2020 • Delaware
This will confirm that in consideration of the Series D-1 Investors’ agreement on the date hereof to purchase shares of Series D-1 Convertible Participating Preferred Stock, par value $0.0001 per share (the “Series D-1 Preferred Stock”), of BioNano Genomics, Inc., a Delaware corporation and successor to BioNanomatrix, LLC (the “Company”), pursuant to the Series D-1 Convertible Participating Preferred Stock Purchase Agreement of even date herewith (as the same may be amended from time to time, the “Purchase Agreement”) between the Company and the Series D-1 Investors and as an inducement to the Series D-1 Investors to consummate the transactions contemplated by the Purchase Agreement, the Company, the Series D-1 Investors and the other signatories hereto hereby agree as follows:
ContractInvestors’ Rights Agreement • May 5th, 2020 • Delaware
EX-4.1 3 ex-41secondamendedandresta.htm EXHIBIT 4.1 Execution Version Exhibit 4.1 SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of September 25th, 2019, by and among IMH Financial Corporation, a Delaware corporation (the “Company”), and each of the other Persons signatory hereto or that executes and delivers a joinder agreement pursuant to Section 8. Capitalized terms used but not otherwise defined herein are defined in Section 13. WHEREAS, the Company and SRE Monarch, LLC, a Delaware limited liability company (“SRE”), are parties to the Series B-2 Cumulative Convertible Preferred Stock Subscription Agreement dated as of July 23, 2014 (the “SRE Purchase Agreement”); WHEREAS, the Company, JCP Realty Partners, LLC, a Delaware limited liability company (“JCP Realty”), and Juniper NVM, LLC, a Delaware limited liability company (“Juniper NVM”), are parties to the Series B-1 Cumulative Conver
EX-10.1 5 d427310dex101.htm EX-10.1 Execution Version ARSANIS, INC. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT Dated as of April 12, 2016 Amended as of November 3, 2017 Page No. - i - ARSANIS, INC. SECOND AMENDED AND RESTATED INVESTORS’...Investors’ Rights Agreement • May 5th, 2020 • Delaware
This Second Amended and Restated Investors’ Rights Agreement (this “Agreement”) is entered into as of 12th day of April, 2016, and amended as of November 3, 2017, by and among Arsanis, Inc., a Delaware corporation (the “Company”) and the individuals and entities listed on Exhibit A attached hereto (the “Investors”).
EX-4.2 4 d541293dex42.htm EX-4.2 VERTICALS ONDEMAND, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT May 16, 2008 PageInvestors’ Rights Agreement • May 5th, 2020 • California
INVESTORS’ RIGHTS AGREEMENTInvestors' Rights Agreement • December 14th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • New York
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of __________, 2017, by and among Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Company”), each of the investors signatory hereto as of the date hereof (each an “Investor”) and each Investor that becomes a party to this Agreement in accordance with Section 5.8 hereof.
